speb/financial-data huggingface dataset:
Stock screener scorecard for VVV (annual, report date 2025-09-30)
Altman Z-score: 2.3992540660110824 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 28.715051001687826%
Earnings yield: 5.660509008060838%
Return on net tangible assets: -17.63681592039801%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.844597503228584%
Free cash flow margin: 1.6079050458983803%
Revenue growth: 5.6392835083384805%
Rule of 40 score: 7.24718855423686
Market cap: 4579820596.889999 (Mid Cap ($2B-$10B))
P/E ratio: 21.736215457475083
Debt to equity: 4.104283604135894
Free cash flow (dilution adjusted): 27500000
Operating income: 391300000
Net income: 210700000
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 1571.HK (annual, report date 2025-12-31)
Altman Z-score: 5.465701188274741 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 17.466323079309205%
Earnings yield: 3.032352225028966%
Return on net tangible assets: 15.50656698541904%
Capitalized R&D asset: 20178846.41102496
ROCI (R&D adjusted): 15.951678572849085%
Rosenberg metric: -0.8607215722481851
Free cash flow margin: 26.46287051694832%
Revenue growth: 2.5021624642873763%
Rule of 40 score: 28.965032981235698
Market cap: 3934335488 (Mid Cap ($2B-$10B))
P/E ratio: 0.7480298369084243
Debt to equity: 0.0109
Free cash flow (dilution adjusted): 119188428.57142858
Operating income: 87678571.42857143
Net income: 75620000
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 1770.T (annual, report date 2026-03-31)
Altman Z-score: 3.5014256892245337 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 17.710374103087084%
Earnings yield: 0.13891894236473082%
Return on net tangible assets: 9.197950245508087%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.607472897932178%
Free cash flow margin: 6.329202027313917%
Revenue growth: -14.643649990880863%
Rule of 40 score: -8.314447963566947
Market cap: 19653859328 (Large Cap ($10B-$200B))
P/E ratio: 0.05060666091984663
Debt to equity: 0.019799999999999998
Free cash flow (dilution adjusted): 11787837.837837838
Operating income: 16382513.763763763
Net income: 11513225.725725725
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 1772.HK (quarterly, report date 2026-03-31)
Altman Z-score: 1.213347121237448 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 5.216553762704641%
Earnings yield: 0.2514541112348377%
Return on net tangible assets: 4.273542776972461%
Capitalized R&D asset: 93109957.41740382
ROCI (R&D adjusted): 2.57291949105915%
Rosenberg metric: 3.5412763159732092
Free cash flow margin: -0.3982256256663535%
Revenue growth: 10.15734961184547%
Rule of 40 score: 9.759123986179116
Market cap: 80471130112 (Large Cap ($10B-$200B))
P/E ratio: 4.325410070570284
Debt to equity: 0.7361
Free cash flow (dilution adjusted): -5299776.989869754
Operating income: 289564354.0709117
Net income: 278159803.24746746
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 3741.T (annual, report date 2026-03-31)
Altman Z-score: 11.637521828579224 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 22.85288954376136%
Earnings yield: 0.044045357062299305%
Return on net tangible assets: 14.273363699548252%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.890731871296914%
Free cash flow margin: 13.955757326423896%
Revenue growth: 2.0147872859917197%
Rule of 40 score: 15.970544612415615
Market cap: 29985630208 (Large Cap ($10B-$200B))
P/E ratio: 0.12176918169351622
Debt to equity: 0.0034999999999999996
Free cash flow (dilution adjusted): 9796452.702702703
Operating income: 11760316.566566566
Net income: 9443649.8998999
Long score: 12 | Short score: 0
Recommendation: Long
Stock screener scorecard for 4169.T (annual, report date 2026-03-31)
Altman Z-score: 3.7135883976328956 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 16.028608648676126%
Earnings yield: 0.06737032199320767%
Return on net tangible assets: 2.259425813681352%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.755807782948711%
Free cash flow margin: 8.923348021830732%
Rule of 40 score: 8.923348021830732
Market cap: 9441550336 (Mid Cap ($2B-$10B))
P/E ratio: 0.5708570523385338
Debt to equity: 0.1182
Free cash flow (dilution adjusted): 3739014.014014014
Operating income: 3708783.7837837837
Net income: 819056.5565565565
Long score: 8 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 6157.T (annual, report date 2026-03-31)
Altman Z-score: 10.540128990479836 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 11.73321727295104%
Earnings yield: 0.09552096400728997%
Return on net tangible assets: 8.894988107533571%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.843583365219862%
Free cash flow margin: 17.398948461732672%
Revenue growth: -5.768592015660219%
Rule of 40 score: 11.630356446072454
Market cap: 22401896448 (Large Cap ($10B-$200B))
P/E ratio: 0.08808911686609527
Debt to equity: 0
Free cash flow (dilution adjusted): 10334534.534534534
Operating income: 12260016.266266266
Net income: 9022628.878878878
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 6752.T (annual, report date 2026-03-31)
Altman Z-score: 2.5674082829126146 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 6.225785580555995%
Earnings yield: 0.01304463448744107%
Return on net tangible assets: 6.625207141749791%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.9269491549523927%
Revenue growth: -10.925390547670633%
Rule of 40 score: -10.925390547670633
Market cap: 9066514481152 (Mega Cap (>= $200B))
P/E ratio: 0.19932902711707393
Debt to equity: 0.2979
Operating income: 1313582332.3323324
Net income: 1307401151.1511512
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 7018.T (annual, report date 2026-03-31)
Altman Z-score: 1.9532142724108588 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 20.481927710843376%
Earnings yield: 0.2348711337700307%
Return on net tangible assets: 23.7914903096458%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.978381536663743%
Free cash flow margin: 26.490981793432027%
Revenue growth: -1.429298407886476%
Rule of 40 score: 25.06168338554555
Market cap: 18354196480 (Large Cap ($10B-$200B))
P/E ratio: 0.06173269806283808
Debt to equity: 0.19440000000000002
Free cash flow (dilution adjusted): 77921671.67167167
Operating income: 19250500.5005005
Net income: 14383133.133133132
Long score: 11 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 8603.HK (annual, report date 2026-03-31)
Altman Z-score: 30.251596567529536 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 29.84659701424293%
Earnings yield: 0.06244914021401025%
Return on net tangible assets: 32.438436611079716%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 25.226172211637675%
Free cash flow margin: 8.35596835505278%
Revenue growth: 34.46249268464536%
Rule of 40 score: 42.81846103969814
Market cap: 11710556160 (Large Cap ($10B-$200B))
P/E ratio: 11.224489795918366
Debt to equity: 0.5756
Free cash flow (dilution adjusted): 6286096.9387755105
Operating income: 8326020.408163265
Net income: 6969515.306122449
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for AETHER.NS (annual, report date 2026-03-31)
Altman Z-score: 16.10795307828706 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 11.817236997584237%
Earnings yield: 0.016242813929167627%
Return on net tangible assets: -13.800236467046545%
Capitalized R&D asset: 73093.27482890312
ROCI (R&D adjusted): 11.66444139036315%
Rosenberg metric: 138.15745322237785
Free cash flow margin: -41.45478868516844%
Revenue growth: 25.120816511551205%
Rule of 40 score: -16.333972173617234
Market cap: 189447208960 (Large Cap ($10B-$200B))
P/E ratio: 0.6994424526612618
Debt to equity: 0.1865
Free cash flow (dilution adjusted): -50967994.91309877
Operating income: 31498622.29758372
Net income: 23258054.26027978
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AETHER.NS (quarterly, report date 2026-03-31)
Altman Z-score: 15.600745665090567 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 2.554958992472809%
Earnings yield: 0.0035117958216352176%
Return on net tangible assets: 2.9619317500974374%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.525894337816012%
Revenue growth: -8.464024732776291%
Rule of 40 score: -8.464024732776291
Market cap: 189447208960 (Large Cap ($10B-$200B))
P/E ratio: 0.6994424526612618
Debt to equity: 0.1865
Operating income: 6810194.997880458
Net income: 5723505.722763883
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AII.TO (quarterly, report date 2026-03-31)
Altman Z-score: 12.598363384128236 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0.4960062979310589%
Earnings yield: 0.04278359716421879%
Return on net tangible assets: -7.507271881497755%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.4591700956007288%
Free cash flow margin: -61.94488188976378%
Revenue growth: 191.3178116756509%
Rule of 40 score: 129.3729297858871
Market cap: 5337184256 (Mid Cap ($2B-$10B))
Debt to equity: 0.4633
Free cash flow (dilution adjusted): -15734000
Operating income: 2243000
Net income: -5264000
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ARCH.OL (quarterly, report date 2026-03-31)
Altman Z-score: -0.24420326406305126 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.381443298969072%
Earnings yield: 0.0601780381953078%
Return on net tangible assets: -21.787709497206706%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.496695550007343%
Free cash flow margin: -2.227011494252874%
Revenue growth: -4.529876383469198%
Rule of 40 score: -6.756887877722072
Market cap: 2392840192 (Mid Cap ($2B-$10B))
P/E ratio: 164.60104469125
Debt to equity: 2.7739999999999996
Free cash flow (dilution adjusted): -637204.5220966084
Operating income: 1747173.6896197328
Net income: 411099.6916752312
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for BESI.AS (quarterly, report date 2026-03-31)
Altman Z-score: 17.364411877578156 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 7.892462497685042%
Earnings yield: 0.36558200934091983%
Return on net tangible assets: 17.81128626913411%
Capitalized R&D asset: 51562958.21501015
ROCI (R&D adjusted): 6.260973003669859%
Rosenberg metric: 0.3886105531162586
Free cash flow margin: 43.95902184672137%
Revenue growth: 8.581042863999064%
Rule of 40 score: 52.540064710720436
Market cap: 20145465344 (Large Cap ($10B-$200B))
P/E ratio: 107.01691039297107
Debt to equity: 1.1360999999999999
Free cash flow (dilution adjusted): 93414942.52873564
Operating income: 73477011.49425288
Net income: 59277011.494252875
Long score: 9 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for COLPAL.NS (annual, report date 2026-03-31)
Altman Z-score: 22.746029943153115 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 139.98216457235512%
Earnings yield: 0.0330541172698008%
Return on net tangible assets: 88.0645914740769%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 103.69329441862143%
Free cash flow margin: 28.724156314708445%
Revenue growth: -9.583363093318479%
Rule of 40 score: 19.140793221389966
Market cap: 567389257728 (Mega Cap (>= $200B))
P/E ratio: 0.38213987522145004
Debt to equity: 0.029900000000000003
Free cash flow (dilution adjusted): 182146036.45612547
Operating income: 182988554.472234
Net income: 140452522.25519288
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for COLPAL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 20.242427182767926 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 38.4718281313336%
Earnings yield: 0.009084388161317654%
Return on net tangible assets: 24.51849934663628%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 28.498420591167324%
Revenue growth: 2.2308433978537616%
Rule of 40 score: 2.2308433978537616
Market cap: 567389257728 (Mega Cap (>= $200B))
P/E ratio: 0.38213987522145004
Debt to equity: 0.029900000000000003
Operating income: 50291437.049597286
Net income: 37443832.13225943
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for DNG.TO (quarterly, report date 2026-03-31)
Altman Z-score: 6.074433556665676 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 8.528768303020346%
Earnings yield: 4.157016815787403%
Return on net tangible assets: 3.2296599259532726%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.518488115683617%
Free cash flow margin: -0.7957752586636592%
Revenue growth: 10.526757319864394%
Rule of 40 score: 9.730982061200736
Market cap: 262179824 (Micro Cap ($50M-$300M))
P/E ratio: 5.499810677773571
Debt to equity: 0.0036
Free cash flow (dilution adjusted): -882148.201438849
Operating income: 9645669.784172663
Net income: 5268335.251798562
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for EME (quarterly, report date 2026-03-31)
Altman Z-score: 5.240127565581303 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 20.229310096096047%
Earnings yield: 1.234906483666464%
Return on net tangible assets: 24.575344669391452%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.616999757607207%
Free cash flow margin: -0.8371229365505152%
Revenue growth: 2.5506074399512%
Rule of 40 score: 1.713484503400685
Market cap: 33170081792 (Large Cap ($10B-$200B))
P/E ratio: 24.771399798590135
Debt to equity: 0.1336
Free cash flow (dilution adjusted): -38744000
Operating income: 403845000
Net income: 305484000
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for EXPO (quarterly, report date 2026-03-31)
Altman Z-score: 7.30003811774262 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 12.134034766697162%
Earnings yield: 1.4059954060663966%
Return on net tangible assets: 8.986443453734875%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.589928519414582%
Free cash flow margin: -7.507982417635279%
Revenue growth: 12.805155163642532%
Rule of 40 score: 5.297172746007252
Market cap: 2980554240 (Mid Cap ($2B-$10B))
P/E ratio: 30.490654205607473
Debt to equity: 0.2395
Free cash flow (dilution adjusted): -12486000
Operating income: 41379000
Net income: 29569000
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for GSK (quarterly, report date 2026-03-31)
Altman Z-score: 1.4425989428151242 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 42.70018621973929%
Earnings yield: 2.547101326495577%
Return on net tangible assets: -27.83573220652318%
Capitalized R&D asset: 5107221194.87909
ROCI (R&D adjusted): 4.598851180961136%
Rosenberg metric: -0.15251959686450164
Free cash flow margin: 9.149298728535852%
Revenue growth: -13.805559966288437%
Rule of 40 score: -4.6562612377525845
Market cap: 102843662336 (Large Cap ($10B-$200B))
P/E ratio: 14.392105263157895
Debt to equity: 1.097
Free cash flow (dilution adjusted): 918421052.6315789
Operating income: 3017105263.1578946
Net income: 2419736842.105263
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for HZO (quarterly, report date 2026-06-30)
Altman Z-score: 1.2062994541033043 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 4.213520988358732%
Earnings yield: 2.1281856994081743%
Return on net tangible assets: 5.158085534226656%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.5192604736228645%
Free cash flow margin: 11.900048751918176%
Revenue growth: 15.897628419527807%
Rule of 40 score: 27.797677171445983
Market cap: 800282880 (Small Cap ($300M-$2B))
P/E ratio: 228.87499999999997
Debt to equity: 1.1514
Free cash flow (dilution adjusted): 72740000
Operating income: 37219000
Net income: 15647000
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for JBMA.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.0263640246683003 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 9.816718001890763%
Earnings yield: 0.008579891057262258%
Return on net tangible assets: 10.140518962075848%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.911408440120093%
Revenue growth: 9.181595633817164%
Rule of 40 score: 9.181595633817164
Market cap: 155152056320 (Large Cap ($10B-$200B))
P/E ratio: 0.5877052405855951
Debt to equity: 1.9028
Operating income: 20468418.821534548
Net income: 8883001.271725308
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for JBMA.NS (annual, report date 2026-03-31)
Altman Z-score: 2.752477523981692 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 26.99063767497179%
Earnings yield: 0.02359003597461933%
Return on net tangible assets: 9.078642714570853%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.002615843206858%
Free cash flow margin: -5.944448185639177%
Revenue growth: 0.8579350223453109%
Rule of 40 score: -5.0865131632938665
Market cap: 155152056320 (Large Cap ($10B-$200B))
P/E ratio: 0.5877052405855951
Debt to equity: 1.9028
Free cash flow (dilution adjusted): -38355235.269181855
Operating income: 56277024.162780836
Net income: 25229970.326409496
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for K.TO (quarterly, report date 2026-03-31)
Altman Z-score: 6.772947242176711 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 12.404601571268238%
Earnings yield: 2.453074916838778%
Return on net tangible assets: 9.325918028642713%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.442695931255823%
Free cash flow margin: 35.29094156248701%
Revenue growth: 17.303847480591923%
Rule of 40 score: 52.59478904307893
Market cap: 40193724416 (Large Cap ($10B-$200B))
P/E ratio: 9.230802669043014
Debt to equity: 0.08310000000000001
Free cash flow (dilution adjusted): 611294964.028777
Operating income: 954172661.8705037
Net income: 615827338.1294965
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for LNTH (quarterly, report date 2026-03-31)
Altman Z-score: 4.672563406742754 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 10.607485473173467%
Earnings yield: 1.1698907343516833%
Return on net tangible assets: 51.670907803066356%
Capitalized R&D asset: 87038850
ROCI (R&D adjusted): 3.6060516303925856%
Rosenberg metric: -0.2096251053074979
Free cash flow margin: 28.054795101409102%
Revenue growth: -7.240416336845418%
Rule of 40 score: 20.814378764563685
Market cap: 6824419328 (Mid Cap ($2B-$10B))
P/E ratio: 18.102625298329354
Debt to equity: 0.5162
Free cash flow (dilution adjusted): 105860000
Operating income: 81326000
Net income: 118417000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for SHI.L (annual, report date 2025-12-31)
Altman Z-score: 2.5567409793027336 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 5.88235294117647%
Earnings yield: 7.133049908162306%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.8004712118981%
Free cash flow margin: 3.894249324585102%
Revenue growth: 7.247150665482847%
Rule of 40 score: 11.14139999006795
Market cap: 98564048 (Micro Cap ($50M-$300M))
Debt to equity: 4.9925
Free cash flow (dilution adjusted): 136351351.35135135
Operating income: 44054054.05405405
Net income: -86621621.62162162
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for SIKA.SW (annual, report date 2025-12-31)
Altman Z-score: 3.533137344575291 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 45.765971512711104%
Earnings yield: 6.480323705653684%
Return on net tangible assets: -122.39962432495889%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.105471943275592%
Free cash flow margin: 11.895940649746011%
Revenue growth: 8.483092752287263%
Rule of 40 score: 20.379033402033272
Market cap: 25004457984 (Large Cap ($10B-$200B))
P/E ratio: 30.786757546251216
Debt to equity: 0.8312999999999999
Free cash flow (dilution adjusted): 1686708860.7594936
Operating income: 1927848101.2658226
Net income: 1323164556.9620252
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for SM (quarterly, report date 2026-03-31)
Altman Z-score: 0.5836054831796388 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.8858672067119917%
Earnings yield: 2.483465512355681%
Return on net tangible assets: -6.668608037274315%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.6843379978471473%
Free cash flow margin: 4.062288422477995%
Revenue growth: 110.31048206238118%
Rule of 40 score: 114.37277048485917
Market cap: 7957259264 (Mid Cap ($2B-$10B))
P/E ratio: 13.067510548523206
Debt to equity: 1.2461
Free cash flow (dilution adjusted): 60000000
Operating income: 399000000
Net income: -335000000
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for SPZ.AX (annual, report date 2025-06-30)
Altman Z-score: 4.142884929627144 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 25.40232201567394%
Earnings yield: 2.0310313966210973%
Return on net tangible assets: 38.28660930100903%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.034452066249049%
Free cash flow margin: 11.804416062607533%
Revenue growth: 38.59961186262069%
Rule of 40 score: 50.40402792522822
Market cap: 273410656 (Micro Cap ($50M-$300M))
P/E ratio: 57.51633986928104
Debt to equity: 0.0941
Free cash flow (dilution adjusted): 5966599.346405229
Operating income: 5136473.202614379
Net income: 3540159.477124183
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for TEGA.NS (quarterly, report date 2026-03-31)
Altman Z-score: 8.645810774707135 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 1.0380813074041342%
Earnings yield: 0.0037419240652113777%
Return on net tangible assets: 2.0422110286734925%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.9721331659074616%
Revenue growth: 24.13969229602359%
Rule of 40 score: 24.13969229602359
Market cap: 117221744640 (Large Cap ($10B-$200B))
P/E ratio: 0.8506157335229052
Debt to equity: 0.11689999999999999
Operating income: 3701886.3925392115
Net income: 4522149.215769394
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for TEGA.NS (annual, report date 2026-03-31)
Altman Z-score: 8.993188732755575 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 4.042398151774852%
Earnings yield: 0.014571447166424601%
Return on net tangible assets: 3.091831817632186%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.7855891297862203%
Free cash flow margin: 12.672051425113008%
Revenue growth: -6.399368778023959%
Rule of 40 score: 6.272682647089049
Market cap: 117221744640 (Large Cap ($10B-$200B))
P/E ratio: 0.8506157335229052
Debt to equity: 0.11689999999999999
Free cash flow (dilution adjusted): 22721810.08902077
Operating income: 14415536.24417126
Net income: 15117952.522255193
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for TIMS3.SA (quarterly, report date 2026-03-31)
Altman Z-score: 1.2368564495639829 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 7.170488162681594%
Earnings yield: 0.4583779823634826%
Return on net tangible assets: 12.424585427256464%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.7109393557346193%
Free cash flow margin: 12.24958623800725%
Revenue growth: 4.351289865388627%
Rule of 40 score: 16.600876103395876
Market cap: 54413869056 (Large Cap ($10B-$200B))
P/E ratio: 2.894194617329057
Debt to equity: 0.6855
Free cash flow (dilution adjusted): 249450760.45627376
Operating income: 299238403.0418251
Net income: 155340874.52471483
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TNPETRO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.020561651495966 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0.3391288121567132%
Earnings yield: 0.004542988663433236%
Return on net tangible assets: 1.5083089819652291%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.3317749962298296%
Revenue growth: -71.92399855106542%
Rule of 40 score: -71.92399855106542
Market cap: 8547289600 (Mid Cap ($2B-$10B))
P/E ratio: 0.07791772052380816
Debt to equity: 0.4567
Operating income: 442984.31538787624
Net income: 857354.811360746
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for TNPETRO.NS (annual, report date 2026-03-31)
Altman Z-score: 2.00473780925199 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 8.528521706677916%
Earnings yield: 0.11424855700959372%
Return on net tangible assets: 12.143215561262139%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.34358555111954%
Free cash flow margin: -24.391759900550525%
Revenue growth: -27.207069621006845%
Rule of 40 score: -51.59882952155737
Market cap: 8547289600 (Mid Cap ($2B-$10B))
P/E ratio: 0.07791772052380816
Debt to equity: 0.4567
Free cash flow (dilution adjusted): -37845485.375158966
Operating income: 11140313.692242475
Net income: 10327469.266638406
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 6904.T (annual, report date 2026-03-31)
Altman Z-score: 2.1226533863693517 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 20.672014962170458%
Earnings yield: 0.0905908038606774%
Return on net tangible assets: 8.206676593400571%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.799309825116081%
Free cash flow margin: 8.5707018309901%
Revenue growth: -11.876246885443752%
Rule of 40 score: -3.3055450544536527
Market cap: 9476065280 (Mid Cap ($2B-$10B))
P/E ratio: 0.14024745993556909
Debt to equity: 1.0261
Free cash flow (dilution adjusted): 22623729.97997998
Operating income: 15002802.802802803
Net income: 2713519.7697697696
Long score: 8 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1772.HK (annual, report date 2025-12-31)
Altman Z-score: 0.7587253270210051 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 2.6206308613522475%
Earnings yield: 0.17151990682499235%
Return on net tangible assets: -7.391665461339125%
Capitalized R&D asset: 290518821.31356627
ROCI (R&D adjusted): 1.7862093473823375%
Rosenberg metric: 1.9097817045669172
Free cash flow margin: -19.395834854312515%
Revenue growth: 27.316390855887356%
Rule of 40 score: 7.920556001574841
Market cap: 22524415132.609257 (Large Cap ($10B-$200B))
P/E ratio: 13.964464073422182
Debt to equity: 0.6528678017573195
Free cash flow (dilution adjusted): -639556394.9985714
Operating income: 197515366.8642857
Net income: 230425856.19142857
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 2170.T (annual, report date 2025-12-31)
Altman Z-score: 3.1093484428159854 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 56.795460686301006%
Earnings yield: 0.034770945109256%
Return on net tangible assets: -353.86792452830196%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.606206845348577%
Free cash flow margin: 11.05438081017292%
Revenue growth: 11.260537126048932%
Rule of 40 score: 22.314917936221853
Market cap: 53775040127.97002 (Large Cap ($10B-$200B))
P/E ratio: 26.621306994044566
Debt to equity: 0.9241198858230255
Free cash flow (dilution adjusted): 29345949.747458603
Operating income: 26878076.84930631
Net income: 12914775.270123394
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7649.T (annual, report date 2026-02-28)
Altman Z-score: 3.8795406952523237 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 23.959648776637728%
Earnings yield: 0.06316572790145898%
Return on net tangible assets: 17.909910513230475%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.686990160406017%
Free cash flow margin: 6.040861653944826%
Revenue growth: 10.750695913417069%
Rule of 40 score: 16.791557567361895
Market cap: 649692459700 (Mega Cap (>= $200B))
P/E ratio: 14.443387570583791
Debt to equity: 0.32374781821374105
Free cash flow (dilution adjusted): 391588605.1584755
Operating income: 311632234.05620426
Net income: 288605158.47555494
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ARCH.OL (annual, report date 2025-12-31)
Altman Z-score: 0.7046859059257808 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 22.179781003310417%
Earnings yield: 0.29850666867939146%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.704200700116687%
Free cash flow margin: 4.027742959806134%
Revenue growth: 21.268811001173905%
Rule of 40 score: 25.296553960980038
Market cap: 2186077237.331176 (Mid Cap ($2B-$10B))
Debt to equity: 2.6417835671342687
Free cash flow (dilution adjusted): 4796019.900497513
Operating income: 8666666.666666666
Net income: -5323383.084577114
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for BESI.AS (annual, report date 2025-12-31)
Altman Z-score: 11.005730455486397 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 22.45614035087719%
Earnings yield: 1.0129804574551415%
Return on net tangible assets: 46.278438348469244%
Capitalized R&D asset: 167818070.4656863
ROCI (R&D adjusted): 16.99904169777822%
Rosenberg metric: 0.36021073714459856
Free cash flow margin: 20.289313430210825%
Revenue growth: 9.940061243099553%
Rule of 40 score: 30.229374673310378
Market cap: 10524897548.140001 (Large Cap ($10B-$200B))
P/E ratio: 79.95151623080955
Debt to equity: 1.2517813528915915
Free cash flow (dilution adjusted): 141149411.76470587
Operating income: 203595294.11764705
Net income: 154871764.70588237
Long score: 10 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DNG.TO (annual, report date 2025-12-31)
Altman Z-score: 7.029718691725686 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 17.684924326259573%
Earnings yield: 8.378324571605813%
Return on net tangible assets: 4.784877219575874%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.635932755752577%
Free cash flow margin: -1.8981002415365138%
Revenue growth: 45.92140608597529%
Rule of 40 score: 44.02330584443878
Market cap: 242463902.16000003 (Micro Cap ($50M-$300M))
P/E ratio: 11.389416034777042
Debt to equity: 0.0038498578421196695
Free cash flow (dilution adjusted): -5508571.532846715
Operating income: 19440516.05839416
Net income: 15539071.532846713
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ELE (annual, report date 2025-12-31)
Altman Z-score: 7.1923663084241305 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0.825687557940276%
Earnings yield: 0.5796053976988164%
Return on net tangible assets: -6.479373154027024%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8228738319850208%
Free cash flow margin: -92.39053227321678%
Revenue growth: 179.080881350081%
Rule of 40 score: 86.69034907686422
Market cap: 1491542341.101 (Small Cap ($300M-$2B))
P/E ratio: 841.7281834655756
Debt to equity: 0.0006265896990703664
Free cash flow (dilution adjusted): -29432116.788321164
Operating income: 5363503.6496350365
Net income: 1293430.6569343065
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for EME (annual, report date 2025-12-31)
Altman Z-score: 6.330033360427762 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 88.88378890367885%
Earnings yield: 4.7964013066972795%
Return on net tangible assets: 117.2145099080248%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 35.43559310048958%
Free cash flow margin: 6.88030710646421%
Revenue growth: 16.616001135786643%
Rule of 40 score: 23.496308242250855
Market cap: 27158342691.36 (Large Cap ($10B-$200B))
P/E ratio: 21.33719355677996
Debt to equity: 0.12740446821357715
Free cash flow (dilution adjusted): 1168718000
Operating income: 1568542000
Net income: 1272817000
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for EXPO (annual, report date 2025-12-31)
Altman Z-score: 8.0457246529179 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 30.330813931406436%
Earnings yield: 4.070179842588643%
Return on net tangible assets: 27.951924638622707%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.980584370418185%
Free cash flow margin: 16.931723291879578%
Revenue growth: 4.207593721912073%
Rule of 40 score: 21.13931701379165
Market cap: 3355549377.9300003 (Mid Cap ($2B-$10B))
P/E ratio: 31.653438650774934
Debt to equity: 0.2122093246674062
Free cash flow (dilution adjusted): 98545000
Operating income: 119787000
Net income: 106009000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for FRSH (annual, report date 2025-12-31)
Altman Z-score: 1.1508613938718004 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.0077507143668507%
Earnings yield: 0.6485471111330964%
Return on net tangible assets: 25.220275208037695%
Capitalized R&D asset: 318942780
ROCI (R&D adjusted): 1.5195940981999738%
Rosenberg metric: 0.6414362962512911
Free cash flow margin: 8.829185189953852%
Revenue growth: 16.43333055717498%
Rule of 40 score: 25.26251574712883
Market cap: 3091401327 (Mid Cap ($2B-$10B))
P/E ratio: 16.826425254323084
Debt to equity: 0.041159153633854646
Free cash flow (dilution adjusted): 74060000
Operating income: 13610000
Net income: 183723000
Long score: 9 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for GSK (annual, report date 2025-12-31)
Altman Z-score: 2.09160176971417 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 135.20350251337766%
Earnings yield: 9.512308585379293%
Return on net tangible assets: -98.51130058194613%
Capitalized R&D asset: 18129237431.57715
ROCI (R&D adjusted): 17.759711128912443%
Rosenberg metric: 0.506103353783404
Free cash flow margin: 13.414148835215967%
Revenue growth: 12.556335019364093%
Rule of 40 score: 25.97048385458006
Market cap: 71450608424.4228 (Large Cap ($10B-$200B))
P/E ratio: 11.361203438451708
Debt to equity: 1.1105540235648033
Free cash flow (dilution adjusted): 5921621621.621622
Operating income: 11267567567.567568
Net income: 8498648648.648649
Long score: 9 | Short score: 3
Recommendation: Long
Stock screener scorecard for HZO (annual, report date 2025-09-30)
Altman Z-score: 1.810642390082362 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 11.627371793425535%
Earnings yield: 5.893666041790466%
Return on net tangible assets: -8.398716262541917%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.938268313993799%
Free cash flow margin: -0.32092142686403774%
Revenue growth: -5.006976529900354%
Rule of 40 score: -5.327897956764391
Market cap: 557973140.8199999 (Small Cap ($300M-$2B))
Debt to equity: 1.313265939607042
Free cash flow (dilution adjusted): -7411000
Operating income: 103072000
Net income: -30766000
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for K.TO (annual, report date 2025-12-31)
Altman Z-score: 8.371251486107045 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 31.715512413664364%
Earnings yield: 6.057734779030016%
Return on net tangible assets: 27.76119402985075%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 29.315715388457527%
Free cash flow margin: 36.20995305696984%
Revenue growth: 42.94412871484759%
Rule of 40 score: 79.15408177181743
Market cap: 46044860893.28 (Large Cap ($10B-$200B))
P/E ratio: 18.64164408634818
Debt to equity: 0.08490815610586491
Free cash flow (dilution adjusted): 1863649635.0364962
Operating income: 2356277372.2627735
Net income: 1802919708.029197
Long score: 13 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for LNTH (annual, report date 2025-12-31)
Altman Z-score: 4.177176803789626 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 41.45513829370762%
Earnings yield: 4.539379168301439%
Return on net tangible assets: 205.6101520772386%
Capitalized R&D asset: 315576970
ROCI (R&D adjusted): 15.923071371784244%
Rosenberg metric: -0.2756665754500351
Free cash flow margin: 17.065027513461583%
Revenue growth: 0.5019199301132401%
Rule of 40 score: 17.566947443574822
Market cap: 4332809757.099999 (Mid Cap ($2B-$10B))
P/E ratio: 18.551242971155038
Debt to equity: 0.5683920950415536
Free cash flow (dilution adjusted): 263076000
Operating income: 315559000
Net income: 233559000
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for PRV.L (annual, report date 2025-11-30)
Altman Z-score: 2.3118755841861103 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 24.357072451936006%
Earnings yield: 8.321341603418231%
Return on net tangible assets: 23.660276863552998%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.987550765800442%
Free cash flow margin: 7.961768663295134%
Revenue growth: 4.669348803775597%
Rule of 40 score: 12.63111746707073
Market cap: 3710720.594 (Nano Cap (< $50M))
P/E ratio: 0.20422237721518988
Debt to equity: 0.08606222529684342
Free cash flow (dilution adjusted): 20321052.63157895
Operating income: 32189473.684210528
Net income: 23907894.736842103
Long score: 13 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BRYN.DE (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.959153632629137%
Capitalized R&D asset: 0
Free cash flow margin: 6.1000384875841%
Revenue growth: -3.2317222651756587%
Rule of 40 score: 2.868316222408441
Market cap: 700223633370.6471 (Mega Cap (>= $200B))
P/E ratio: 10.410699276994455
Debt to equity: 0.17935314984097606
Free cash flow (dilution adjusted): 25042000000
Net income: 67260000000
Long score: 4 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for CTZ.V (annual, report date 2025-10-31)
Altman Z-score: 26.533499300957054 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 23.025520289308552%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 29.64320688134916%
Free cash flow margin: 27.115067213830397%
Revenue growth: 14.547794635628284%
Rule of 40 score: 41.66286184945868
Market cap: 32759357.04 (Nano Cap (< $50M))
P/E ratio: 13.176959272501728
Debt to equity: 0
Free cash flow (dilution adjusted): 1528438.5714285716
Operating income: 2284147.142857143
Net income: 1775792.142857143
Long score: 12 | Short score: 0
Recommendation: Long
Stock screener scorecard for DMAC (annual, report date 2025-12-31)
Altman Z-score: 44.21963293494016 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -58.389620573506086%
Capitalized R&D asset: 41708490
ROCI (R&D adjusted): -29.311624014050796%
Rule of 40 score: 0
Market cap: 428911426.2 (Small Cap ($300M-$2B))
Debt to equity: 0.004277236192546916
Free cash flow (dilution adjusted): -32948000
Operating income: -34397000
Net income: -32766000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for ETL.PA (annual, report date 2025-06-30)
Altman Z-score: 0.42878939090863494 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.541614673253449%
Free cash flow margin: -0.450269357562113%
Revenue growth: 12.18088356529752%
Rule of 40 score: 11.730614207735407
Market cap: 4369712611.81 (Mid Cap ($2B-$10B))
Debt to equity: 1.1906354515050166
Free cash flow (dilution adjusted): -6588235.294117647
Operating income: -1069647058.8235295
Net income: -1272823529.4117646
Long score: 0 | Short score: 8
Recommendation: Short
Stock screener scorecard for ETO (annual, report date 2025-10-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 17.354539454029375%
Capitalized R&D asset: 0
Free cash flow margin: 38.03764741241683%
Revenue growth: -22.3716192635569%
Rule of 40 score: 15.66602814885993
Market cap: 443299132.90000004 (Small Cap ($300M-$2B))
P/E ratio: 5.0223234716407035
Debt to equity: 0.2025154292032475
Free cash flow (dilution adjusted): 33760697
Net income: 88265747
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for HCWB (annual, report date 2025-12-31)
Altman Z-score: -8.370932926859833 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -250.2175769476582%
Capitalized R&D asset: 12256694.260000002
ROCI (R&D adjusted): -78.38322408381312%
Rosenberg metric: -0.1484673486937067
Free cash flow margin: -26110.48827260658%
Revenue growth: -97.88716810711581%
Rule of 40 score: -26208.375440713695
Market cap: 9309623.84 (Nano Cap (< $50M))
Debt to equity: 2.462851326819709
Free cash flow (dilution adjusted): -14160240
Operating income: -11257288
Net income: -7959709
Long score: 0 | Short score: 13
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for HEPS (annual, report date 2025-12-31)
Altman Z-score: 1.9754936761239728 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -25.35266911639823%
Free cash flow margin: 10.222487833102702%
Revenue growth: -6.797580374899384%
Rule of 40 score: 3.424907458203318
Market cap: 33789559403.2 (Large Cap ($10B-$200B))
Debt to equity: 1.2059200754028156
Free cash flow (dilution adjusted): 201478975.55296856
Operating income: -20992293.364377182
Net income: -132693271.24563445
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for JARA.L (annual, report date 2025-02-28)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.061203492061535%
Capitalized R&D asset: 0
Free cash flow margin: -21.417631041524846%
Rule of 40 score: -21.417631041524846
Market cap: 243664.5615 (Nano Cap (< $50M))
P/E ratio: 0.02476769277292133
Debt to equity: 0
Free cash flow (dilution adjusted): -3186075.9493670883
Net income: 12453164.556962024
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for MRLN (annual, report date 2024-12-31)
Altman Z-score: -3.931382093366561 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 43674230
ROCI (R&D adjusted): -64.2843896513839%
Rosenberg metric: -0.30560622643803964
Free cash flow margin: -4001.6273393002443%
Revenue growth: 22.532402791625124%
Rule of 40 score: -3979.0949365086194
Market cap: 951727152.7199999 (Small Cap ($300M-$2B))
Debt to equity: -0.2832910083484132
Free cash flow (dilution adjusted): -49180000
Operating income: -54025000
Net income: -55253000
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MSIF (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.012038031080648%
Capitalized R&D asset: 0
Free cash flow margin: -72.16420819399708%
Revenue growth: 55.445355104123486%
Rule of 40 score: -16.718853089873598
Market cap: 572710242.27 (Small Cap ($300M-$2B))
P/E ratio: 6.454673184000542
Debt to equity: 0.816007115597319
Free cash flow (dilution adjusted): -70350000
Net income: 88728000
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MVBF (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.537045465433813%
Capitalized R&D asset: 0
Free cash flow margin: -1.353985353215314%
Revenue growth: -17.267900988784923%
Rule of 40 score: -18.621886342000238
Market cap: 327800974.51 (Small Cap ($300M-$2B))
P/E ratio: 12.16781642576095
Debt to equity: 0.2216559670387582
Free cash flow (dilution adjusted): -1688000
Net income: 26940000
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NEV.V (annual, report date 2025-09-30)
Altman Z-score: -10.797032798706077 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -95.44464418818781%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -55.24435480334985%
Rule of 40 score: 0
Market cap: 4823794.74 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -561542.4460431655
Operating income: -453222.3021582734
Net income: -664303.5971223022
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for OPY (annual, report date 2025-12-31)
Altman Z-score: 2.162454563882657 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 22.473527461145043%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.209322454749106%
Free cash flow margin: 9.239770437300947%
Revenue growth: 14.350825412426982%
Rule of 40 score: 23.59059584972793
Market cap: 763694396.5999999 (Small Cap ($300M-$2B))
P/E ratio: 5.146084624973889
Debt to equity: 0.6303397393656553
Free cash flow (dilution adjusted): 151354000
Operating income: 424259000
Net income: 148403000
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for PPR.TO (annual, report date 2025-12-31)
Altman Z-score: -2.673887928303882 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.487890838500537%
Free cash flow margin: -72.76054249288397%
Revenue growth: 0.9063578218786243%
Rule of 40 score: -71.85418467100534
Market cap: 28052187.599999998 (Nano Cap (< $50M))
Debt to equity: -1.06279255622788
Free cash flow (dilution adjusted): -22203649.635036495
Operating income: -5800000
Net income: -10261313.868613139
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for REAT.L (annual, report date 2025-09-30)
Altman Z-score: 1.9673443912777755 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.401091405184175%
Free cash flow margin: 0.7420182897481149%
Revenue growth: 21.783791599204385%
Rule of 40 score: 22.525809888952498
Market cap: 115819.38900000001 (Nano Cap (< $50M))
Debt to equity: 0.41513600321188404
Free cash flow (dilution adjusted): 250000
Operating income: 475675.6756756757
Net income: -459459.45945945947
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for RPID (annual, report date 2025-12-31)
Altman Z-score: -8.833506514965597 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -134.67746792748298%
Capitalized R&D asset: 27613590
ROCI (R&D adjusted): -56.51718293118917%
Rosenberg metric: 0.07919435500445297
Free cash flow margin: -107.0205734361509%
Revenue growth: 19.73548180100531%
Rule of 40 score: -87.28509163514559
Market cap: 131434612 (Micro Cap ($50M-$300M))
Debt to equity: 0.7189664518460519
Free cash flow (dilution adjusted): -35945000
Operating income: -47392000
Net income: -47123000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for RSF (annual, report date 2025-06-30)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.757862788215281%
Capitalized R&D asset: 0
Free cash flow margin: 1109.0565451925681%
Revenue growth: -47.38608415405226%
Rule of 40 score: 1061.670461038516
Market cap: 52557524.79 (Micro Cap ($50M-$300M))
P/E ratio: 14.846380964890722
Debt to equity: 0
Free cash flow (dilution adjusted): 67226505
Net income: 3540090
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for RW.V (annual, report date 2025-12-31)
Altman Z-score: 2.2085183393091845 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.634313405258359%
Capitalized R&D asset: 2566254.153016691
ROCI (R&D adjusted): 3.4900783800109836%
Rosenberg metric: 0.6289423887350372
Free cash flow margin: -3.771721116919517%
Revenue growth: 16.358908540911727%
Rule of 40 score: 12.58718742399221
Market cap: 18814598.46 (Nano Cap (< $50M))
P/E ratio: 1015.9619018305524
Debt to equity: 0
Free cash flow (dilution adjusted): -213070.80291970802
Operating income: -38523.357664233576
Net income: 13517.518248175182
Long score: 3 | Short score: 8
Recommendation: Neutral